Shc family expression in neuroblastoma: High expression of shcC is associated with a poor prognosis in advanced neuroblastoma

Clinical Cancer Research

Volumn 11, Issue 9, 2005, Pages 3280-3287

  Terui, Elena ^a   Matsunaga, Tadashi ^a   Yoshida, Hideo ^a   Kouchi, Katsunori ^a   Kuroda, Hiroaki ^a   Hishiki, Tomoro ^a   Saito, Takeshi ^a   Yamada, Shin Ichi ^a   Shirasawa, Hiroshi ^a   Ohnuma, Naomi ^a  

^a CHIBA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN SHC; PROTEIN SHCA; PROTEIN SHCB; PROTEIN SHCC; RETINOIC ACID; UNCLASSIFIED DRUG;

ADVANCED CANCER; ARTICLE; CANCER MODEL; CELL DIFFERENTIATION; CHILD; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; GENE AMPLIFICATION; HUMAN; HUMAN CELL; HUMAN TISSUE; INFANT; MAJOR CLINICAL STUDY; MALE; NEUROBLASTOMA; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; PROTEIN FAMILY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; CELL DIFFERENTIATION; CELL LINE, TUMOR; CHILD; CHILD, PRESCHOOL; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INFANT; MALE; NEUROBLASTOMA; NUCLEAR PROTEINS; ONCOGENE PROTEINS; PROGNOSIS; RECEPTOR, TRKA; RECEPTOR, TRKB; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SURVIVAL ANALYSIS; SURVIVAL RATE; TRETINOIN;

EID: 20944437880     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-04-1681     Document Type: Article

References (33)

1. Brodeur GM, Nakagawara A. Molecular basis of clinical heterogeneity in neuroblastoma. Am J Pediatr Hematol Oncol 1992;14:111-6.
2. Brodeur GM, Pritchard J, Berthold F, et al. Revision of the international criteria for neuroblastoma diagnosis, staging, and response to treatment. J Clin Oncol 1993; 11:1466-77.
3. Snider WD. Functions of the neurotrophins during nervous system development: what knockouts are teaching us. Cell 1994;77:627-38.
4. Nakagawara A, Brodeur GM. Role of neurotrophin and their receptors in human neuroblastomas: a primary culture study. Eur J Cancer 1997;33:2050-3.
5. Nakagawara A, Arima-Nakagawara M, Scavarda NJ, Azar CG, Cantor AB, Brodeur GM. Association between high levels of expression of the trk gene and favorable outcome in human neuroblastoma. New Engl J Med 1993;328:847-54.
6. Nakagawara A, Azar CG, Scavarda NJ, Brodeur GM. Expression and function of TRK-B and BDNF in human neuroblastomas. Mol Cell Biol 1994;14:759-67.
7. Jaboin J, Kim CJ, Kaplan DR, Thiele CJ. Brain-derived neurotrophic factor activation of TrkB protects neuroblastoma cells from chemotherapy-induced apoptosis via phosphatidylinositol 3′-kinase pathway. Cancer Res 2002;62:6756-63.
8. Ho R, Eggert A, Hishiki T, et al. Resistance to Chemotherapy mediated by TrkB in neuroblastomas. Cancer Res 2002;62:6462-6.
9. Bibel M, Barde YA. Neurotrophins: key regulators of cell fate and cell shape in the vertebrate nervous system. Genes Dev 2000;14:2919-37.
10. Conti L, Sipione S, Magrassi L, et al. She signaling in differentiating neural progenital cells. Nat Neurosci 2001;4:579-86.
11. Pelicci G, Lanfrancone L, Grignani F, et al. A novel transforming protein (SHC) with an SH2 domain is implicated in mitogenic signal transduction. Cell 1992;70: 93-104.
12. Migliaccio E, Mele S, Salcini AE, et al. Opposite effects of the p52shc/p46shc and p66shc splicing isoforms on the EGF receptor-MAP kinase-fos signaling pathway. EMBO J 1997;16:706-16.
13. Pelicci G, Lanfrancone L, Salcini AE, et al. Constitutive phosphorylation of She proteins in human tumors. Oncogene 1995;11:899-907.
14. Nakamura T, Muraoka S, Sanokawa R, Mori N. N-Shc and Sck, two neuronally expressed She adapter homologs. J Biol Chem 1998;273:6960-7.
15. Sakai R, Henderson JT, O'Bryan JP, Elia AJ, Saxton TM, Pawson T. The Mammalian ShcB and ShcC phosphotyrosine docking proteins function in the maturation of sensory and sympathetic neurons. Neuron 2000;28:819-33.
16. Nakamura T, Sanokawa R, Sasaki Y, Ayusawa D, Oishi M, Mori N. N-Shc: a neural-specific adaptor molecule that mediates signaling from neurotrophin/Trk to Ras/MARK pathway. Oncogene 1996;13:1111-21.
17. Miyake I, Hakomori Y, Shinohara A, et al. Activation of anaplastic lymphoma kinase is responsible for hyperphosphorylation of ShcC in neuroblastoma cell lines. Oncogene 2002;21:5823-34.
18. Sugimoto T, Kuroda H, Horii Y, Moritake H, Tanaka T, Hattori S. Signal transduction pathways through TRK-A and TRK-B receptors in human neuroblastoma cells. Jpn J Cancer Res 2001;92: 152-60.
19. Eggert A, Ikegaki N, Liu X, et al. Molecular dissection of trkA signal transduction pathways mediating differentiation in human neuroblastoma cells. Oncogene 2000;19:2043-51.
20. Shimada H, Ambros IM, Dehner LP, Hata J, Joshi VV, Roald B. Terminology and morphologic criteria of neuroblastic tumors. Cancer 2000;86:349-63.
21. Chomezynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987;162: 156-9.
22. Matsunaga T, Shirasawa H, Enomoto H, et al. Neuronal src and trkA proto-oncogene expression in neuroblastomas and patient prognosis. Int J Cancer 1998;79:226-31.
23. Matsunaga T, Shirasawa H, Tanabe M, Ohnuma N, Takahashi H, Simizu B. Expression of alternatively spliced src messenger RNAs related to neuronal differentiation in human neuroblastomas. Cancer Res 1993; 53:3179-85.
24. Matsunaga T, Shirasawa H, Tanabe M, et al. Expression of neuronal src mRNA as a favorable marker and inverse correlation to N-myc gene amplification in human neuroblastomas. Int J Cancer 1994;58: 793-8.
25. Stephens RM, Loeb DM, Copeland TD, Pawson T, Greene LA, Kaplan DR. Trk receptors use redundant signal transduction pathways involving She and PLC-γ1 to mediate NGF responses. Neuron 1994;12: 691-705.
26. Obermier A, Bradshaw RA, Seedorf K, Choidas A, Schlessinger J, Ulrich A. Neuronal differentiation signals are controlled by nerve growth factor receptor/Trk binding sites for SHC and PLCγ. EMBO J 1994;13: 1585-90.
27. Atwal JK, Massie B, Miller FD, Kaplan DR. The TrkB-Shc site signals neuronal survival and local axongrowth via MEK and PI3-kinase. Neuron 2000;27:265-77.
28. Brodeur GM, Seeger RC, Schwab M, Varmus H, Bishop JM. Amplification of N-myc in untreated human neuroblastomas correlates with advanced disease stage. Science 1984;224:1121-4.
29. O'Bryan JP, Songyang Z, Cantley L, Der CJ, Pawson T. A mammalian adaptor protein with conserved Src homology 2 and phosphotyrosine-binding domains is related to Shc and is specifically expressed in the brain. Proc Natl Acad Sci U S A 1996;93:2729-34.
30. Liu H, Meakin SO. ShcB and ShcC activation by the Trk family of receptor tyrosine kinases. J Biol Chem 2002;277:26046-56.
31. Yamada M, Numakawa T, Koshimizu H, et al. Distinct usages of phospholipase Cγ and She in intracellular signaling stimulated by neurotrophins. Brain Res 2002;955:183-90.
32. Aoyama M, Asai K, Shishikura T, et al. Human neuroblastomas with unfavorable biologies express high levels of brain-derived neurotrophic factor mRNA and a variety of its variants. Cancer Lett 2001;164:51-60.
33. Middlemas DS, Kihl BK, Moody NM. Brain derived neurotrophic factor protects human neuroblastoma cells from DNA damaging agents. J Neurooncol 1999;45:27-36.